Quantum Cyber N.V. (NasdaqCM: QUCY)
Health Care · Biotechnology · DE
$1.02
-0.97% today · -34.4% 1Y
Quantum Cyber N.V. (NasdaqCM: QUCY) operates in the Biotechnology industry within the Health Care sector. The company is valued at $86.59M and employs 13 people.
Over the last twelve months the share price has lost 34.4%, trading between 0.30 and 4.93.
Tweenvest scores Quantum Cyber N.V. across four factors: quality 36/100, value 59/100, growth 0/100. Its strongest factor is value.
QUCY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $86.59M
- Revenue (TTM)
- $537.08K
- P/E
- —
- EPS
- -2.08
- Dividend yield
- —
- Beta (5Y)
- 2.38
- 52-week high
- $4.93
- 52-week low
- $0.30
- Avg volume (3M)
- —
- Shares outstanding
- 84.07M
- Employees
- 13
- Next earnings
- —
About Quantum Cyber N.V.
Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026. The company is headquartered in Mainz, Germany.
- ISIN
- NL0015000LC2
- Listed since
- Nov 5, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Citius Oncology, Inc.NasdaqCM: CTOR | $88.82M | $0.81 | -3.24% |
| Bonraybio Co., Ltd.TWSE: 6955 | $88.36M | NT$93.00 | -0.53% |
| Y-Biologics, Inc.KOSDAQ: A338840 | $87.21M | ₩7,630.00 | -10.45% |
| Revium Rx.OTCPK: RVRC | $86.84M | $— | — |
| Devyser Diagnostics AB (publ)OM: DVYSR | $85.81M | Skr51.00 | +0.39% |
| AnGes, Inc.TSE: 4563 | $85.64M | ¥34.00 | -2.86% |
| ReproCELL IncorporatedTSE: 4978 | $85.24M | ¥130.00 | -1.52% |
| ProMIS Neurosciences, Inc.NasdaqCM: PMN | $84.74M | $9.45 | -1.66% |
Figures last refreshed Oct 11, 2026.